A detailed history of Whittier Trust CO Of Nevada Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 21 shares of MRNA stock, worth $520. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Holding current value
$520
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$23.51 - $34.67 $493 - $728
21 New
21 $0
Q1 2025

May 02, 2025

BUY
$28.35 - $47.53 $141 - $237
5 New
5 $0
Q1 2024

May 02, 2024

BUY
$85.37 - $115.44 $170 - $230
2 Added 66.67%
5 $0
Q4 2023

Jan 11, 2024

BUY
$69.51 - $104.43 $208 - $313
3 New
3 $0
Q1 2023

Apr 21, 2023

SELL
$135.66 - $197.02 $7,325 - $10,639
-54 Reduced 94.74%
3 $0
Q4 2022

Jan 25, 2023

BUY
$118.38 - $210.04 $6,747 - $11,972
57 New
57 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Whittier Trust CO Of Nevada Inc Portfolio

Follow Whittier Trust CO Of Nevada Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.